- Home
- AMKR vs CRNX Comparison
AMKR vs CRNX Comparison
Compare AMKR & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMKR
- CRNX
- Stock Information
- Founded
- AMKR 1968
- CRNX 2008
- Country
- AMKR United States
- CRNX United States
- Employees
- AMKR N/A
- CRNX N/A
- Industry
- AMKR Semiconductors
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- AMKR Technology
- CRNX Health Care
- Exchange
- AMKR Nasdaq
- CRNX Nasdaq
- Market Cap
- AMKR 6.1B
- CRNX 5.2B
- IPO Year
- AMKR 1998
- CRNX 2018
- Fundamental
- Price
- AMKR $22.24
- CRNX $37.46
- Analyst Decision
- AMKR Buy
- CRNX Strong Buy
- Analyst Count
- AMKR 8
- CRNX 12
- Target Price
- AMKR $31.71
- CRNX $72.64
- AVG Volume (30 Days)
- AMKR 1.8M
- CRNX 710.8K
- Earning Date
- AMKR 02-10-2025
- CRNX 02-27-2025
- Dividend Yield
- AMKR 3.25%
- CRNX N/A
- EPS Growth
- AMKR N/A
- CRNX N/A
- EPS
- AMKR 1.43
- CRNX N/A
- Revenue
- AMKR $6,317,692,000.00
- CRNX $1,038,999.00
- Revenue This Year
- AMKR $9.23
- CRNX N/A
- Revenue Next Year
- AMKR $7.59
- CRNX $206.01
- P/E Ratio
- AMKR $15.56
- CRNX N/A
- Revenue Growth
- AMKR N/A
- CRNX N/A
- 52 Week Low
- AMKR $21.46
- CRNX $34.07
- 52 Week High
- AMKR $44.86
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- AMKR 36.81
- CRNX 42.29
- Support Level
- AMKR $21.46
- CRNX $35.10
- Resistance Level
- AMKR $23.30
- CRNX $35.85
- Average True Range (ATR)
- AMKR 0.76
- CRNX 1.45
- MACD
- AMKR -0.06
- CRNX 0.47
- Stochastic Oscillator
- AMKR 22.16
- CRNX 49.78
About AMKR Amkor Technology Inc.
Amkor Technology Inc is a provider of outsourced semiconductor packaging and test services to integrated device manufacturers, fabless semiconductor companies, and contract foundries. The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.